Cargando…
Incorporating BEAMing technology as a liquid biopsy into clinical practice for the management of colorectal cancer patients: an expert taskforce review
The importance of mutation identification for advanced colorectal cancer treatment with anti-epidermal growth factor receptor agents is well established. However, due to delays in turnaround time, low-quality tissue samples, and/or lack of standardization of testing methods a significant proportion...
Autores principales: | García-Foncillas, J, Alba, E, Aranda, E, Díaz-Rubio, E, López-López, R, Tabernero, J, Vivancos, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834030/ https://www.ncbi.nlm.nih.gov/pubmed/28945877 http://dx.doi.org/10.1093/annonc/mdx501 |
Ejemplares similares
-
Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer
por: García-Foncillas, Jesús, et al.
Publicado: (2018) -
Comparison of the Clinical Sensitivity of the Idylla Platform and the OncoBEAM RAS CRC Assay for KRAS Mutation Detection in Liquid Biopsy Samples
por: Vivancos, Ana, et al.
Publicado: (2019) -
European Society of Paediatric Radiology Artificial Intelligence taskforce: a new taskforce for the digital age
por: Laborie, Lene Bjerke, et al.
Publicado: (2022) -
Report of the Onlin: Tier-0 Taskforce
por: Åkesson, T, et al.
Publicado: (2004) -
1st TaskForce Meeting
por: Haywood, S
Publicado: (1999)